Community-Associated Methicillin-ResistantStaphylococcus aureus: A Review
- 1 January 2005
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 25 (1) , 74-85
- https://doi.org/10.1592/phco.25.1.74.55620
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial pathogen responsible for a variety of infections in both children and adults. Treatment of infections caused by this organism is problematic due to its resistance to many drugs. Recent reports of community-associated MRSA (CA-MRSA) infections in patients with no known risk factors have serious public health implications. Therapeutic options for these infections are untested; therefore, the potential exists for high morbidity and mortality. Recently, clinical definitions have been established, and new molecular approaches have allowed investigators to distinguish CA-MRSA more easily from traditional nosocomial-derived MRSA strains. Identifying potential risk factors for CA-MRSA acquisition and fully characterizing the epidemiologic, clinical, and molecular properties of these strains are necessary to provide effective therapeutic guidelines.Keywords
This publication has 77 references indexed in Scilit:
- Antimicrobial Use and Methicillin-Resistant in a Large Nursing HomeJournal of the American Medical Directors Association, 2004
- Community-acquired methicillin-resistant Staphylococcus aureus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreakJournal of the American Academy of Dermatology, 2004
- Community-acquired methicillin-resistant staphylococcus aureus skin infection: an emerging clinical problemJournal of the American Academy of Dermatology, 2004
- Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureusThe Pediatric Infectious Disease Journal, 2004
- Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2003
- Identification of a Novel Methicillin-Resistant Staphylococcus aureus Epidemic Clone in Córdoba, Argentina, Involved in Nosocomial InfectionsJournal of Clinical Microbiology, 2002
- In Vitro Activities of Daptomycin against 2,789 Clinical Isolates from 11 North American Medical CentersAntimicrobial Agents and Chemotherapy, 2001
- Emergence of Methicillin-Resistant Staphylococcus aureus with Intermediate Glycopeptide ResistanceDrugs, 2001
- Increase in Community‐Acquired Methicillin‐ResistantStaphylococcus aureusin ChildrenClinical Infectious Diseases, 1999
- Nosocomial and Community-Acquired Staphylococcus aureus Bacteremias from 1980 to 1993: Impact of Intravascular Devices and Methicillin ResistanceClinical Infectious Diseases, 1996